Healthcare :: Licensing Opportunities for Rare Disease Technologies

The National Institutes of Health (NIH) launched a new website today offering technologies available for commercial licensing that are related to rare diseases or conditions. The listing can be found at http://www.ott.nih.gov/rarediseases and currently consists of more than 500 such technologies, including drugs, biologics, and devices, available to be transferred from the NIH and the U.S. Food and Drug Administration (FDA) to the private sector for further research and development and potential commercialization.

Nystagmus :: Leicester breakthrough in eye disease

Researchers at the University of Leicester have identified for the first time a gene which causes a distressing eye condition. Their discovery, as reported in the journal Nature Genetics, is expected to lead to better treatments for the condition.

FDA Investigating Norovirus Outbreak Linked to Oysters

The U.S. Food and Drug Administration (FDA) is currently working with five states and the Centers for Disease Control and Prevention to investigate an outbreak of norovirus which has been associated with raw, frozen oysters on the half shell from South Korea.

Folic Acid :: Folic acid won’t cut heart, stroke risk

An analysis of previous studies suggests that for people with a history of vascular disease, folic acid supplementation does not decrease the risk of coronary heart disease or stroke, as has been suggested in some research, according to a review article in the December 13 issue of JAMA.

Dr. Anil Singhal Homeopathic Doctor | Dr. Anil Singhal's Blog | Manan - My Memoir by Dr. Anil Singhal | Boger's Legacy | Organon of Medicine | Health Newstrack